OtherIUPHAR Nomenclature Report
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Janet J. Maguire, William A. E. Parker, Steven M. Foord, Tom I. Bonner, Richard R. Neubig and Anthony P. Davenport
Pharmacological Reviews March 2009, 61 (1) 1-8; DOI: https://doi.org/10.1124/pr.109.001107
Janet J. Maguire
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
William A. E. Parker
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
Steven M. Foord
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
Tom I. Bonner
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
Richard R. Neubig
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
Anthony P. Davenport
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (J.J.M., W.A.E.P, A.P.D.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherIUPHAR Nomenclature Report
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Janet J. Maguire, William A. E. Parker, Steven M. Foord, Tom I. Bonner, Richard R. Neubig and Anthony P. Davenport
Pharmacological Reviews March 1, 2009, 61 (1) 1-8; DOI: https://doi.org/10.1124/pr.109.001107
OtherIUPHAR Nomenclature Report
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Janet J. Maguire, William A. E. Parker, Steven M. Foord, Tom I. Bonner, Richard R. Neubig and Anthony P. Davenport
Pharmacological Reviews March 1, 2009, 61 (1) 1-8; DOI: https://doi.org/10.1124/pr.109.001107
Jump to section
- Article
- Abstract
- I. Introduction
- II. Trace Amine Receptors
- III. Receptor Structure
- IV. Distribution of Receptor and mRNA Encoding the Receptor
- V. Radiolabeled Ligands
- VI. Agonists
- VII. Antagonists
- VIII. Receptor Signaling
- IX. Physiological Role
- X. Pathophysiological Role
- XI. Genetically Modified Animals
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement